Sign in

Research summary ·

The impact of subclinical hypothyroidism on core reproductive hormones and ovarian endocrine status in patients with polycystic ovary syndrome: a systematic review and meta-analysis.

Written based on 1 research study on PubMed, searched on 13 Nov 2026.

What was studied

This review pooled results from earlier papers. It looked at women with polycystic ovary syndrome, or PCOS. Some also had subclinical hypothyroidism, or SCH, a thyroid problem. The team compared sex hormone levels in the blood. They set women with SCH against women with normal thyroid tests. The papers only watched people and gave no treatment.

What they found

The review covered 3,114 people in all. Of these, 579 had SCH and 2,535 had normal thyroid levels. Levels of FSH, LH, estradiol and total testosterone did not differ clearly. Prolactin looked higher once one odd paper was left out. The authors call this prolactin result exploratory.

What it means for patients

In this review, SCH was not linked to changes in FSH, LH, estradiol or testosterone. Whether SCH affects prolactin in PCOS is still unclear. The authors say firm conclusions cannot be drawn yet. The review aimed to give doctors evidence for their care.

Why it is not certain yet

The papers only watched people, so they cannot show cause and effect. Results varied a lot from paper to paper. The authors rated how sure the evidence is as low or very low. Tests for missing small papers were too weak for some hormones. For prolactin, small papers may have pushed the result up or down.

Source

The impact of subclinical hypothyroidism on core reproductive hormones and ovarian endocrine status in patients with polycystic ovary syndrome: a systematic review and meta-analysis.

PubMed · PMID 42798498

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Hypothyroidism publications